SCHEMBL19786436

SCHEMBL19786436

Cc1ccc(C(C#N)c2c(Cl)cc(C)cc2Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
GAA P10253 4/20 0.53
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 4/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 1/20 0.40
NR1I2 O75469 1/20 0.40
KMT2A Q03164 1/20 0.40
GABRA1 P14867 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRB2 P47870 1/20 0.37
PKM P14618 1/20 0.35
CYP2A6 P11509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8035378 0.80 ALDH1A1 (0.59) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL29031406 0.79 ALDH1A1 (0.57) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL29031363 0.78 ALDH1A1 (0.53) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL29031409 0.75 ALDH1A1 (0.54) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL29031400 0.74 ALDH1A1 (0.49) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL10419854 0.74 ALDH1A1 (0.46) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL8145600 0.73 MEN1 (0.48) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL19346861 0.73 ALDH1A1 (0.44) ALDH1A1GAALMNASMN1; SMN2TDP1
SCHEMBL13482210 0.73 ALDH1A1 (0.43) ALDH1A1GAALMNAL3MBTL1GABRA1
SCHEMBL9447402 0.72 ALDH1A1 (0.54) ALDH1A1GAALMNASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011375-A1 MECLOZINE DERIVATIVES AND DICLAZURIL DERIVATIVES FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF DISORDERS ASSOCIATED TO THE INFLAMMATION INDUCED BY P. ACNES UNIVERSITE PARIS DESCARTES (FR) 2018-01-18 WO disclosed